Company profile
Lumos PBC
Computational drug safety intelligence. Multi-organ. Continuous. AI-native.
- Industry
- Biotechnology Research
- Employees
- 7
- Headquarters
- Princeton, NJ
- Founded
- 2026
- LinkedIn followers
- 141
- Office locations
- 1
Lumos PBC company summary
Lumos PBC is a company in the Biotechnology Research industry, headquartered in Princeton, NJ, founded in 2026. On LinkedIn the company has around 7 employees and 141 followers. Its listed specialties include Drug Safety, Computational Pharmacology, Clinical Trials, Phase I Safety Monitoring, Foundation Models.
What technology does Lumos PBC use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Lumos PBC
Lumos Health builds AI that predicts how drugs affect multiple organ systems simultaneously — cardiac, renal, hepatic, respiratory, metabolic — from continuous physiological data. Every Phase I clinical trial monitors safety with disconnected, single-timepoint measurements analyzed weeks later. Lumos processes the same data your trial already collects — continuous ECG waveforms, vital signs, lab results, drug administration records — and predicts multi-organ drug effects in real time. Cross-organ interactions that single-endpoint monitoring misses become visible hours to days earlier. Our foundation model was trained on 42,000+ ICU patients and 200+ drugs. It learned how human physiology responds to pharmacological intervention by ingesting continuous waveforms fused with clinical data. In validation, the model discovered known drug-organ interactions — nephrotoxicity, respiratory depression, cardiac perturbation — in a fully unsupervised setting. No labels. No prior pharmacological knowledge. Just physiological signal. Built for the drugs that need it most: novel mechanisms with no historical safety database. RNA therapeutics. Gene therapies. Combination regimens. If there is no reference compound to benchmark against, Lumos provides the computational safety baseline. Founded by a Princeton mathematician, backed by pharma and healthcare investors, and advised by clinicians from Penn Medicine, Princeton, and Harvard. We are accepting early access partners for Phase I safety monitoring. Contact: zach@projectlumos.org
Specialties
Where is Lumos PBC located?
Lumos PBC lists 1 location.
Compare companies similar to Lumos PBC
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Lumos PBC projectlumos.org | Biotechnology Research | 7 | 2026 | Princeton, NJ |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Lumos PBC
What does Lumos PBC do?
Lumos Health builds AI that predicts how drugs affect multiple organ systems simultaneously — cardiac, renal, hepatic, respiratory, metabolic — from continuous physiological data. Every Phase I clinical trial monitors safety with disconnected, single-timepoint measurements analyzed weeks later. Lumos processes the same data your trial already collects — continuous ECG waveforms, vital signs, lab results, drug administration records — and predicts multi-organ drug effects in real time. Cross-organ interactions that single-endpoint monitoring misses become visible hours to days earlier. Our foundation model was trained on 42,000+ ICU patients and 200+ drugs. It learned how human physiology responds to pharmacological intervention by ingesting continuous waveforms fused with clinical data. In validation, the model discovered known drug-organ interactions — nephrotoxicity, respiratory depression, cardiac perturbation — in a fully unsupervised setting. No labels. No prior pharmacological knowledge. Just physiological signal. Built for the drugs that need it most: novel mechanisms with no historical safety database. RNA therapeutics. Gene therapies. Combination regimens. If there is no reference compound to benchmark against, Lumos provides the computational safety baseline. Founded by a Princeton mathematician, backed by pharma and healthcare investors, and advised by clinicians from Penn Medicine, Princeton, and Harvard. We are accepting early access partners for Phase I safety monitoring. Contact: zach@projectlumos.org
How many employees does Lumos PBC have?
Lumos PBC has around 7 employees on LinkedIn.
Where is Lumos PBC headquartered?
Lumos PBC is headquartered in Princeton, NJ.
When was Lumos PBC founded?
Lumos PBC was founded in 2026.
Build a lead list from companies like Lumos PBC
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.